Logo image of ALKOM.PA

PLASTICOS COMPUESTOS SA (ALKOM.PA) Stock Fundamental Analysis

EPA:ALKOM - Euronext Paris - Matif - ES0105425005 - Common Stock - Currency: EUR

1.01  0 (0%)

Fundamental Rating

1

Taking everything into account, ALKOM scores 1 out of 10 in our fundamental rating. ALKOM was compared to 0 industry peers in the Unkown industry. ALKOM has a bad profitability rating. Also its financial health evaluation is rather negative. ALKOM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALKOM has reported negative net income.
ALKOM had a positive operating cash flow in the past year.
ALKOM had negative earnings in 4 of the past 5 years.
Each year in the past 5 years ALKOM had a positive operating cash flow.
ALKOM.PA Yearly Net Income VS EBIT VS OCF VS FCFALKOM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 1M -1M 2M -2M

1.2 Ratios

Industry RankSector Rank
ROA -0.6%
ROE -1.59%
ROIC 4.26%
ROA(3y)-1.59%
ROA(5y)-1.63%
ROE(3y)-4.44%
ROE(5y)-4.5%
ROIC(3y)N/A
ROIC(5y)N/A
ALKOM.PA Yearly ROA, ROE, ROICALKOM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10

1.3 Margins

In the last couple of years the Operating Margin of ALKOM has declined.
ALKOM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.96%
PM (TTM) N/A
GM 18.43%
OM growth 3YN/A
OM growth 5Y-2.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.67%
GM growth 5Y0.94%
ALKOM.PA Yearly Profit, Operating, Gross MarginsALKOM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

More info and screens

2

2. Health

2.1 Basic Checks

ALKOM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALKOM has less shares outstanding
The number of shares outstanding for ALKOM has been reduced compared to 5 years ago.
ALKOM has a better debt/assets ratio than last year.
ALKOM.PA Yearly Shares OutstandingALKOM.PA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ALKOM.PA Yearly Total Debt VS Total AssetsALKOM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

ALKOM has an Altman-Z score of 1.53. This is a bad value and indicates that ALKOM is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of ALKOM is 10.96, which is on the high side as it means it would take ALKOM, 10.96 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.31 indicates that ALKOM is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 10.96
Altman-Z 1.53
ROIC/WACC0.42
WACC10.21%
ALKOM.PA Yearly LT Debt VS Equity VS FCFALKOM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.94 indicates that ALKOM may have some problems paying its short term obligations.
ALKOM has a Quick Ratio of 0.94. This is a bad value and indicates that ALKOM is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.33
ALKOM.PA Yearly Current Assets VS Current LiabilitesALKOM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 84.50% over the past year.
Looking at the last year, ALKOM shows a very negative growth in Revenue. The Revenue has decreased by -10.74% in the last year.
Measured over the past years, ALKOM shows a small growth in Revenue. The Revenue has been growing by 2.22% on average per year.
EPS 1Y (TTM)84.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-76.92%
Revenue 1Y (TTM)-10.74%
Revenue growth 3Y2.31%
Revenue growth 5Y2.22%
Sales Q2Q%-10.94%

3.2 Future

Based on estimates for the next years, ALKOM will show a decrease in Earnings Per Share. The EPS will decrease by -2.22% on average per year.
The Revenue is expected to decrease by -15.12% on average over the next years. This is quite bad
EPS Next Y-80.43%
EPS Next 2Y-24.82%
EPS Next 3Y-2.22%
EPS Next 5YN/A
Revenue Next Year-46.53%
Revenue Next 2Y-24.74%
Revenue Next 3Y-15.12%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALKOM.PA Yearly Revenue VS EstimatesALKOM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
ALKOM.PA Yearly EPS VS EstimatesALKOM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.05 0.1 0.15 0.2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ALKOM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 7.69 indicates a rather cheap valuation of ALKOM.
ALKOM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE N/A
Fwd PE 7.69
ALKOM.PA Price Earnings VS Forward Price EarningsALKOM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF 15.03
EV/EBITDA 4.75
ALKOM.PA Per share dataALKOM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as ALKOM's earnings are expected to decrease with -2.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.82%
EPS Next 3Y-2.22%

More info and screens

0

5. Dividend

5.1 Amount

ALKOM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLASTICOS COMPUESTOS SA

EPA:ALKOM (3/7/2025, 7:00:00 PM)

1.01

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap12.28M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.69
P/S 0.28
P/FCF 15.03
P/OCF 5.99
P/B 0.92
P/tB 1.19
EV/EBITDA 4.75
EPS(TTM)-0.02
EYN/A
EPS(NY)0.13
Fwd EY13%
FCF(TTM)0.07
FCFY6.66%
OCF(TTM)0.17
OCFY16.7%
SpS3.57
BVpS1.1
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE -1.59%
ROCE 5.79%
ROIC 4.26%
ROICexc 4.63%
ROICexgc 5.43%
OM 2.96%
PM (TTM) N/A
GM 18.43%
FCFM 1.89%
ROA(3y)-1.59%
ROA(5y)-1.63%
ROE(3y)-4.44%
ROE(5y)-4.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-4.56%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.62%
OM growth 3YN/A
OM growth 5Y-2.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.67%
GM growth 5Y0.94%
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 10.96
Debt/EBITDA 1.04
Cap/Depr 46%
Cap/Sales 2.85%
Interest Coverage 0.84
Cash Conversion 51.74%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.33
Altman-Z 1.53
F-Score6
WACC10.21%
ROIC/WACC0.42
Cap/Depr(3y)35.45%
Cap/Depr(5y)82.3%
Cap/Sales(3y)1.88%
Cap/Sales(5y)3.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-76.92%
EPS Next Y-80.43%
EPS Next 2Y-24.82%
EPS Next 3Y-2.22%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.74%
Revenue growth 3Y2.31%
Revenue growth 5Y2.22%
Sales Q2Q%-10.94%
Revenue Next Year-46.53%
Revenue Next 2Y-24.74%
Revenue Next 3Y-15.12%
Revenue Next 5YN/A
EBIT growth 1Y619.99%
EBIT growth 3YN/A
EBIT growth 5Y-0.82%
EBIT Next Year-13.41%
EBIT Next 3Y6.53%
EBIT Next 5YN/A
FCF growth 1Y119.72%
FCF growth 3Y10.27%
FCF growth 5YN/A
OCF growth 1Y162.66%
OCF growth 3Y-13.28%
OCF growth 5Y1.48%